Speakers
Junaid Bajwa
Senior Partner
Flagship Pioneering
Kate Bingham
Managing Partner
SV Health Investors
David Bredt, M.D., Ph.D.
Founder, Chief Scientific Officer
Rapport Therapeutics
Peter Campbell, Ph.D.
Academic Co-Founder & Chief Scientific Officer
Quotient Therapeutics
Matthew Coghlan, Ph.D.
VP, External Innovation & Data Science - Diabetes Obesity & Cardiometabolic TA
Eli Lilly and Co.
Sarah Cole, Ph.D.
CEO
SENISCA Ltd.
Miles Congreve, Ph.D.
Chief Scientific Officer
Isomorphic Labs
Lee Cronin
CEO, Chemify and Regius Professor of Chemistry
University of Glasgow
Kevin Eggan
Chief Scientific Officer
Biomarin
Simone Fishburn, Ph.D.
VP & Editor in Chief
BioCentury Inc.
Tim Funnell
Partner
Monograph Capital
Shaun Grady
Chair, U.K.
AstraZeneca
Anika Gupta, Ph.D.
Principal
GV
Stephen Hansen
Director of Biopharma Intelligence
BioCentury Inc.
Susan Hill, Ph.D.
CEO
Mestag Therapeutics
Anne Horgan, Ph.D.
Partner
Cambridge Innovation Capital (CIC)
Steve Jackson, Ph.D.
Professor of Biology, Cambridge and Group Leader
Cancer Research UK
Annalisa Jenkins
Non-Executive Director
LetterOne
Selina Koch, Ph.D.
Executive Editor, Head of Intelligence & Research
BioCentury Inc.
Laura Lane, Ph.D.
VP, Lilly Ventures & European Head
Eli Lilly and Co.
John Lepore, M.D.
CEO
ProFound Therapeutics
Jing Liang, Ph.D.
Managing Partner
Umbrex
Husseini Manji, M.D.
Professor, Oxford University & Visiting Professor, Duke University and Co-chair,
UK Govt Mental Health Mission
Paul Nioi, Ph.D.
SVP, Research
Alnylam Pharmaceuticals
Stephen O'Rahilly
Professor of Clinical Biochemistry and Medicine
University of Cambridge
Jane Osbourn, Ph.D.
CEO
Alchemab Therapeutics Ltd.
Slavé Petrovski, Ph.D.
VP, Centre for Genomics Research
AstraZeneca
Koustubh Ranade, Ph.D.
SVP and Head of Translational Medicine
Immunocore
Kiran Reddy, M.D.
Senior Managing Director
Blackstone
Steve Rees
SVP Discovery Sciences
AstraZeneca
James Sabry, M.D., Ph.D.
EVP & Chief Business Officer
BioMarin
Chris Sheldon, Ph.D.
SVP & Global Head of Business Development R&D
GlaxoSmithKline
Otello Stampacchia, Ph.D.
Founder and Managing Director
Omega Funds
Paul Peter Tak, M.D., Ph.D.
President and CEO
Candel Therapeutics
Victoria Taylor
Associate
Medicxi
Sarah Teichmann
Professor and Chair
Cambridge Stem Cell Institute
Richard Tillyer, Ph.D.
Global Head, Discovery, Product Development and Supply
Johnson & Johnson Innovative Medicine
Karen Tkach Tuzman, Ph.D.
Director of Biopharma Intelligence and Head of Discovery and Preclinical Research
BioCentury Inc.
Patrick Vallance, KCB
Minister of State for Science, Research and Innovation
Department for Science, Innovation and Technology
Jérôme Van Biervliet, Ph.D.
Managing Director
VIB
Alice Vickers, Ph.D.
Biotech Investment Associate
Forbion
Annelise Vuidepot, Ph.D.
SVP, CTO, Research and UK Site Lead
Immunocore Holdings plc
Douglas Williams, Ph.D.
CEO
TriArm Therapeutics